2026 ICD-10-CM Diagnosis Code D68.51Activated protein C resistance
ICD-10-CM Codes›D50–D89›D65-D69›D68
- Billable — Valid for Submission
- Chronic Condition
D68.51 is a billable ICD-10-CM diagnosis code for activated protein C resistance. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 814 through 816. Coders also document this condition as factor V Leiden mutation. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Coagulation and hemorrhagic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Factor V Leiden mutation
- Heterozygous Factor V Leiden mutation
- Homozygous Factor V Leiden mutation
- Resistance to activated protein C due to factor V Leiden mutation
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Factor V Leiden mutation
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Activated protein C resistance - D68.51
- Hypercoagulable (state) - D68.59
- activated protein C resistance - D68.51
- factor V Leiden mutation - D68.51
- factor V Leiden - D68.51
- activated protein C - D68.51
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Activated protein C resistance
- Hypercoagulable(state)
- activated protein C resistance
- Hypercoagulable(state)
- factor V Leiden mutation
- Mutation(s)
- factor V Leiden
- Resistance, resistant(to)
- activated protein C
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Activated Protein C Resistance
a hemostatic disorder characterized by a poor anticoagulant response to activated protein c (apc). the activated form of factor v (factor va) is more slowly degraded by activated protein c. factor v leiden mutation (r506q) is the most common cause of apc resistance.
Patient EducationClinical
Bleeding Disorders
Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert D68.51 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About D68.51Overview
Is D68.51 (Primary thrombophilia) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report activated protein C resistance on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does D68.51 group to?
When activated protein C resistance is the principal diagnosis on an inpatient stay, it groups to MS-DRG 814, 815, 816, with relative weights from 0.6320 to 2.1267 depending on complications. Higher weights mean higher Medicare reimbursement.
What is the ICD-9 equivalent of D68.51?
Under the General Equivalence Mappings, activated protein C resistance converts to ICD-9-CM 289.81 (prim hypercoagulable st). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
